about
Phototoxicity: Its Mechanism and Animal Alternative Test MethodsCharacterization of paliperidone photodegradation products by LC-Q-TOF multistage mass spectrometry.Improving the isotretinoin photostability by incorporating in microemulsion matrixCyclodextrins in drug delivery.Effect of counterion on the solid state photodegradation behavior of prazosin salts.Sunscreen use: controversies, challenges and regulatory aspects.Photosensitivity: a current biological overview.Photo, thermal and chemical degradation of riboflavin.Photodegradation of fleroxacin injection: different products with different concentration levels.Discovery pharmaceutics--challenges and opportunities.Design of pediatric oral formulations with a low proportion of methadone or phenobarbital for the treatment of neonatal abstinence syndrome.Photodegradation of fleroxacin injection: II. Kinetics and toxicological evaluation.Increasing doxycycline hyclate photostability by complexation with β-cyclodextrinSolvent Effect on the Photolysis of Riboflavin.Indigotine, azorubine, and cochineal red as photoprotectors of manidipine.Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms.Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins.Assessing impact of manufacturing and package configurations to photosensitive compounds.Study of photodegradation kinetics of melatonin by multivariate curve resolution (MCR) with estimation of feasible band boundaries.Titanium dioxide inclusion in backing reduce the photoallergenicity of ketoprofen transdermal patchPhotostability and Photostabilization of Drugs and Drug Products
P2860
Q26801908-BD6012E1-6109-43E9-89D2-BD5AB95BA833Q33466161-AB99B39E-7F28-43CC-8A6D-FEF38CEECDACQ35687781-468768B1-0A88-43B8-B674-9BE757CF8236Q36316735-21386936-21A4-4FB7-A97F-BCC3B48D1C84Q36882109-4BC64291-5A43-4905-8B95-ABC19E39AB3AQ37853628-EA9EA81B-C35D-4D9D-90A6-30A38741DAC7Q37984420-BB9108D3-72CE-4A19-A135-48699FC05564Q38253360-8228A404-16DC-410C-A602-ED58BC78DA37Q38312195-D0122D82-1F72-45E0-A299-33238BB4E916Q39628531-3E929750-B9E5-4FAC-8088-8B055584549DQ40757531-86666F87-A8F3-497C-8072-CB43B37A0B53Q41124808-63D65ED4-DB5E-400F-9DE9-4A012D9430DBQ42761629-8FC7C941-94F7-44B3-85FB-4143358C9A63Q43136722-BEBC172A-D63F-4211-992A-58EAAE057C11Q43296466-509D6CDB-1B77-4628-B1B6-71D34B8F8987Q46223241-9D2EA047-5B4C-4BF4-9EFF-AE73E0911387Q48567652-A97D8FE2-DB94-4402-B206-493FDB94BE03Q48933500-D2889E7F-7697-464C-A21C-CAEE26D4752EQ53235767-D99D1B47-9C0C-410D-910A-8345EFF09C61Q57099361-79C5273E-0437-496B-963A-4F318F795A9BQ59124786-1A9C77D9-7797-4C2F-929A-3995E5D014D5
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Formulation and stability testing of photolabile drugs.
@ast
Formulation and stability testing of photolabile drugs.
@en
Formulation and stability testing of photolabile drugs.
@nl
type
label
Formulation and stability testing of photolabile drugs.
@ast
Formulation and stability testing of photolabile drugs.
@en
Formulation and stability testing of photolabile drugs.
@nl
prefLabel
Formulation and stability testing of photolabile drugs.
@ast
Formulation and stability testing of photolabile drugs.
@en
Formulation and stability testing of photolabile drugs.
@nl
P1476
Formulation and stability testing of photolabile drugs.
@en
P2093
Tønnesen HH
P356
10.1016/S0378-5173(01)00746-3
P407
P577
2001-08-01T00:00:00Z